COVlD-19 vaccinated individuals may be ill…See more…

As COVlD-19 continues to circulate in 2026, updated vac.cines remain an important tool for reducing the risk of severe illness, hospitalization, and death. While vaccinated people can still experience breakthrough infections, protection against serious outcomes remains a major benefit.

### How Do They Work?

Vac.cines train the immune system to recognize SARS-CoV-2 and respond more quickly when exposed. Different platforms remain available, including mRNA, protein-based, and adenovirus-vectored technologies. Updated formulations are designed to better match newer circulating variants.

### Protection Against Severe Illness

Recent real-world evidence suggests that updated doses can provide meaningful protection against hospitalization and emergency or urgent-care visits. However, protection can decline over time, which is why recommendations may include additional doses for people at higher risk.

### Are They Safe?

Most reported reactions are mild and temporary, including fatigue, fever, and soreness around the injection site. Serious adverse events are uncommon, while researchers continue monitoring long-term safety and effectiveness, particularly among children and people with weakened immune systems.

### What Comes Next?

Future research will focus on developing better variant-adapted formulations, understanding how long protection lasts, and improving access worldwide.

Although no vac.cine provides perfect protection against infection, COVlD-19 vac.cination remains an important public-health measure, particularly for older adults and other higher-risk groups.